实用医学杂志 ›› 2023, Vol. 39 ›› Issue (1): 1-5.doi: 10.3969/j.issn.1006⁃5725.2023.01.001

• 述评 •    下一篇

提高非经典21羟化酶缺乏症临床诊治水平: 局限与展望

张莹 刘恩    

  1. 广州医科大学附属第三医院内分泌代谢科(广州510150)

  • 出版日期:2023-01-10 发布日期:2023-01-10
  • 基金资助:
    广东省自然科学基金项目(编号:2021A1515111148);广州市卫生健康科技项目(编号:20221A011091);广州市科技计划项目(编号:202102010084)

Clinical diagnosis,treatment and progress of non ⁃ classical 21 hydroxylase deficiency 

ZHANG Ying,LIU En.   

  1. Department of Endocrinology and Metabolism,the Third Affiliated Hospital of Guangzhou Medical University Guangzhou 510150,China

  • Online:2023-01-10 Published:2023-01-10

摘要:

非经典 21 羟化酶缺乏症(NC⁃21OHD)是最常见的常染色体隐性遗传病之一,但其临床表现 多种多样,缺乏特异性,常与多囊卵巢综合征(PCOS)混淆,极易漏诊误诊。同时,NC⁃21OHD 患者的循证 诊断和治疗、随访管理策略仍然面临许多困难,有不少具争议性的科学问题,本文着重从其临床特征、诊 断与治疗等方面进行系统地阐述,以期提高临床对该病的认识。

关键词:

先天性肾上腺增生症, 非经典型 21?羟化酶缺乏症, 17?羟基孕酮, CYP21A2 基因, 多囊卵巢综合征, 生育力

Abstract:

Non⁃classical 21⁃hydroxylase deficiency(NC⁃21OHD)is one of the most frequent autosomal recessive hereditary diseases. Its phenotype is usually considered diverse and lack specificity,such as polycystic ovarian syndrome(PCOS)and frequently misdiagnosed. Meanwhile,evidence ⁃ based diagnosis and follow ⁃ up management strategies faces many difficulties and many controversial scientific problems due to NC ⁃ 21OHD. We systematically discuss the clinical features,diagnosis and therapy to improve the awareness of the disease.

Key words:

congenital adrenal hyperplasia, nonclassic 21?hydroxylase deficiency, 17?hydroxyproges? terone, CYP21A2 gene, polycystic ovary syndrome, fertility